Literature DB >> 3305807

Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease).

W J Shih, W R Markesbery, D B Clark, S Goldstein, P A Domstad, J J Coupal, H Kung, S T DeKosky, F H DeLand.   

Abstract

Decreased perfusion of the left frontal and left temporoparietal cortex has been shown in [123I] HIPDM planar and single photon emission computed tomographic images of a patient with Creutzfeldt-Jakob disease (CJD) that was proven by brain biopsy and subsequent autopsy. An EEG showed diffuse, periodic discharges most prominent to the left hemisphere. Concurrent head computed tomography (CT), nuclear magnetic resonance (NMR), and cerebral angiographic studies were negative. Abnormalities demonstrated by [123I]HPDM imaging and by EEG may represent changes in neurophysiological and neurochemical status while cerebral angiography, CT, and possibly NMR register only anatomic or structural lesions. Premortem diagnosis of CJD depends on brain biopsy; the availability of the [123I] HIPDM study may provide regional cerebral neurochemical and neurophysiological information, guiding or avoiding brain biopsy in the appropriate clinical setting.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305807

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.

Authors:  F Grünwald; C Pohl; H Bender; A Hartmann; C Menzel; J Ruhlmann; E Keller; H J Biersack
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

2.  Serial MR imaging in Creutzfeldt-Jakob disease.

Authors:  A Uchino; M Yoshinaga; O Shiokawa; H Hata; M Ohno
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 3.  Neuroimaging Correlates of Periodic Discharges.

Authors:  Aline Herlopian; Aaron F Struck; Eric Rosenthal; Brandon M Westover
Journal:  J Clin Neurophysiol       Date:  2018-07       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.